← Back to Clinical Trials
Recruiting NCT06745102

NCT06745102 Hop Compounds on the Immune System in Overweight People

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06745102
Status Recruiting
Phase
Sponsor University of Vienna
Condition Inflammatory Response
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2024-02-01
Primary Completion 2025-10-01

Trial Parameters

Condition Inflammatory Response
Sponsor University of Vienna
Study Type INTERVENTIONAL
Phase N/A
Enrollment 24
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2024-02-01
Completion 2025-10-01
Interventions
XanthohumolIso-alpha AcidsXanthohumol + Iso-alpha Acids

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aim of the present study is to determine the effect of Iso-alpha Acids and Xanthohumol from hops on the immune response in overweight participants.

Eligibility Criteria

Inclusion Criteria: * BMI 25 - 29,9 kg/m² as well as one or more of the following incipient metabolic diseases: * pre-diabetes (fasting blood glucose 100-125 mg/dL), * fatty liver (grade 1-3), * high-normal blood pressure to mild hypertension (grade 1, systolic 140-159 mmHg) Exclusion Criteria: * History of diseases that could falsify the study results * inflammatory bowel diseases * malignant diseases of the gastrointestinal tract * food allergies * malabsorption * kidney or liver disease (except simple fatty liver) * symptomatic heart failure * Taking medication to treat these diseases * Consumption of special diets (e.g. vegan, gluten-free) * Pregnancy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology